Alnylam Pharmaceuticals | ALNY - Trade Debtors

Stock Price
321.18
Daily Change
-6.07 -1.85%
Monthly
-0.37%
Yearly
41.94%
Q2 Forecast
309.25

Alnylam Pharmaceuticals reported $777.57M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Moderna USD 184M 862M Dec/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Sanofi EUR 397M 186.13M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Takeda JPY 757.92B 55.68B Dec/2025
Tectonic Therapeutic USD 0 270K Dec/2023
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025
Xencor USD 29.3M 7.49M Dec/2025